BFM
ADAP

Boothbay Fund Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Boothbay Fund Management’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-33,851
Closed -$380K – 605
2018
Q1 		$380K Buy
+33,851
New +$380K 0.05% 301